高级检索

云南省艾滋病抗病毒治疗中HIV低病毒血症发生情况分析

Incidence of low-level viraemia among HIV/AIDS patients with antiviral therapy in Yunnan province, 2004 – 2018: a retrospective analysis

  • 摘要:
      目的  了解云南省抗病毒治疗中HIV低病毒血症发生的总体情况和变化趋势,为后续相关研究提供参考。
      方法  从艾滋病综合防治数据信息管理系统下载既有数据,对2004 — 2018年在云南省接受艾滋病抗病毒治疗(ART)的患者人口学特征和病毒载量(VL)检测结果进行描述性分析,按照治疗方案分为2个子队列进行统计分析。
      结果  93944例患者中有21203例发生低病毒血症(LLV),总发生率为22.6 %,其中25.5 %发生了至少2次。按数值水平看,51~199拷贝/mL的发生率最高,然后是400~999、200~399拷贝/mL;按发生频率看,发生单独1次LLV的比例最高,连续2次、间隔2次、连续多次、间隔多次发生LLV的比例依次下降。按随访年分析,开始ART第1年低病毒血症的发生率最高,此后逐年下降。按自然年分析,一线治疗队列中 LLV 51~199拷贝/mL与LLV 200~399拷贝/mL发生率有相同趋势,先上升至2010年的峰值,之后开始下降至2016年谷值,之后又上升;LLV 400~999拷贝/mL与病毒学失败(VF)≥ 1000拷贝/mL发生率相似,2012年前逐年下降,之后平稳维持。二线治疗队列中4种VL检测结果有相同趋势,均在2008 — 2012年有下降趋势,之后平稳维持。
      结论  云南省ART人群中LLV发生率较高,应进一步探索LLV对ART治疗效果的影响。

     

    Abstract:
      Objective  To examine general situation and change trend of low-level viraemia (LLV) among human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) patients under antiviral therapy (ART) in Yunnan province and to provide evidences to further relevant studies.
      Methods  From the Data and Information Management System for Integrated HIV/AIDS Prevention and Control of Chinese Center for Disease Control and Prevention, we extracted demographical, clinical and viral load (VL) detection data on all HIV/AIDS patients receiving ART at the age of more than 15 years in Yunnan province during the period from 2004 through 2018. The incidence of LLV among the HIV/AIDS patients with different ART regimens was analyzed statistically.
      Results  Of the 93 944 HIV/AIDS patients included in the study, 21 203 (22.6%) were detected with LLV. Among the patients with LLV, 25% were detected with LLV at least two times; the most detected LLV level was 51 – 199 copies/mL, followed by 400 – 999 and 200 – 399 copies/mL; the once-only LLV was detected most frequently and the detection frequency decreased in turn for successive two times, discontinuous two times, successive several times, and discontinuous several times; the detected incidence of LLV was the highest during the first year of ART and the incidence declined yearly after the initiation of ART. During the retrospective observation period among the 76 736 HIV/AIDS patients receiving first-line ART, the detected frequency of 51 – 199 and 200 – 399 copies/mL LLV increased first, with the highest frequency in 2010, then declined, with the lowest frequency in 2016, and increased again; the detected frequency of 400 – 999 copies/mL LLV and virologic failure (VF) of ≥ 1 000 copies/mL decreased yearly before 2012 and then remained at a stable level. While among the 17 208 HIV/AIDS patients receiving second-line ART, the detected frequencies of the four levels of LLV mentioned above varied similarly, with a decreasing trend between 2008 – 2012 and a stabilization later after.
      Conclusion  The detected incidence of LLV is relatively high among HIV/AIDS patients with different ART regimen in Yunnan province. The effect of LLV on outcomes of ART needs to be explored.

     

/

返回文章
返回